Functional redundancy as a therapeutic strategy for genetic hearing loss
- 21 August 2026
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (9) , 5049-5050
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Rescue of stereocilia architecture and hearing function by AAV-CIB2 and AAV-CIB3 in a mouse model of recessive deafness DFNB48Molecular Therapy, 2026
- DB-OTO Gene Therapy for Inherited DeafnessNew England Journal of Medicine, 2026
- Author Correction: Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48Nature Genetics, 2025
- Mechano-electrical transduction components TMC1-CIB2 undergo a Ca2+-induced conformational change linked to hearing lossDevelopmental Cell, 2025
- Structures of the TMC-1 complex illuminate mechanosensory transductionNature, 2022
- CIB2 and CIB3 are auxiliary subunits of the mechanotransduction channel of hair cellsNeuron, 2021
- CIB2, defective in isolated deafness, is key for auditory hair cell mechanotransduction and survivalEMBO Molecular Medicine, 2017
- CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cellsNature Communications, 2017
- Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48Nature Genetics, 2012